Trump's Drug Tariffs: 100% on Branded Meds, 20% on Production Shifts
Business & Finance News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Trump Administration Mulls 100% Tariffs on Branded Drugs: A Summary
The Trump administration is considering imposing a 100% tariff on branded drugs and their key ingredients from pharmaceutical companies that havent agreed to lower U.S. prices. This plan, which could be announced as early as this week, is part of Trumps ongoing effort to link American drug costs to lower foreign prices through his most favored nation policy.
Over a dozen major pharmaceutical companies, including Eli Lilly, Pfizer, and Novo Nordisk, have already signed deals since November, agreeing to reduce prices on new and existing medications. These deals grant them a three-year tariff exemption while they renegotiate their pricing strategies.
For companies that choose to onshore their production, tariffs start at 20% and increase to 100% after four years. Exemptions are available for companies in discussions with the Health and Human Services department, and generic drugs will face no additional duties. Tariff rates for other regions, such as the EU, Japan, and the UK, will vary based on separate agreements.
The White House has not yet commented on the proposed plan, but it is expected to intensify pressure on drug prices as negotiations continue across the industry.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/d92c671dd0e83e06